Biological kits
Ended Awarded Last action
- Contract number
- 75N91022F00001
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,711
Award facts
- Contract value 100% obligated
- $16,711.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute issued a BPA call to 10X Genomics, Inc. for biological kits with a ceiling value of $16,711.40, awarded on June 21, 2022. Place of performance is Pleasanton, California. The call runs through July 12, 2022. No set-aside was used.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on June 21, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $16,711 on 75N91022F00001.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a BPA call under 75N98022A00032, a blanket purchase agreement.
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award